Cargando…
Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study
BACKGROUND: Parkinson’s disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal m...
Autores principales: | Liebert, Ann, Bicknell, Brian, Laakso, E-Liisa, Heller, Gillian, Jalilitabaei, Parastoo, Tilley, Sharon, Mitrofanis, John, Kiat, Hosen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249215/ https://www.ncbi.nlm.nih.gov/pubmed/34215216 http://dx.doi.org/10.1186/s12883-021-02248-y |
Ejemplares similares
-
Microbiome Changes in Humans with Parkinson’s Disease after Photobiomodulation Therapy: A Retrospective Study
por: Bicknell, Brian, et al.
Publicado: (2022) -
A Potential Role for Photobiomodulation Therapy in Disease Treatment and Prevention in the Era of COVID-19
por: Liebert, Ann, et al.
Publicado: (2020) -
A Role for Photobiomodulation in the Prevention of Myocardial Ischemic Reperfusion Injury: A Systematic Review and Potential Molecular Mechanisms
por: Liebert, Ann, et al.
Publicado: (2017) -
Photophysical Mechanisms of Photobiomodulation Therapy as Precision Medicine
por: Liebert, Ann, et al.
Publicado: (2023) -
“Photobiomics”: Can Light, Including Photobiomodulation, Alter the Microbiome?
por: Liebert, Ann, et al.
Publicado: (2019)